Abstract C084: Distance traveled for cervical cancer treatment and its impact on five-year survival

Abstract Objective: To evaluate the impact of distance from patient residence to treatment facility and five-year cervical cancer survival. Materials and Methods: To assess five-year cervical cancer survival, cervical cancer data were obtained from the National Cancer Database (NCDB) years 2004-2017, only from patients with a minimum follow-up time of 5 years. It covers more than 70% of newly diagnosed cancer cases in the United States. Women younger than 20 years old were excluded from this study, as well as women with race other than white or black (Hispanic origin was not distinguished). Five-year survival was calculated. SAS version 9.4 was used for statistical analysis. Results: 50,582 patients met study criteria, with 79% white and 13.5% who had stage III/IV disease. Insurance type was 56% private, 18% Medicaid, 13% Medicare, and 11% uninsured or unknown. Distance between residence zip code and hospital was less than 50 miles (80%), more than 50 miles (14%), and 7% unknown. Rural-Urban status was 96% Urban, 1.5% Rural, and 2.9% unknown. Whites were more likely to travel more than 50 miles to a treatment facility (P <0.0001). Travel of more than 50 miles was associated with race (P <0.0001), insurance (P <0.0001), facility type (P <0.0001), stage (P <0.0001), age (P <0.0001), geographic location (P <0.0001), income (P <0.0001), education (P <0.0001), and Rural-Urban status (P <0.0001). White, Medicaid/Medicare insured, academic/research program facility, stage I, younger age, those who lived in the South, income <$50,353, and less education were more likely to travel more than 50 miles to treatment facility. In the adjusted model for five-year survival, insurance (P <0.0001), facility type (P <0.0001), comorbidity (P <0.0001), distance (P=0.0485), stage (P <0.0001), age (P <0.0001), geographic location (P=0.0074), income (P=0.0014), and education (P=0.0184) were associated with survival. Conclusion: Fourteen percent (14%) of patients resided more than 50 miles from treatment facility. Medicaid/Medicare, non-academic/research program facility, higher comorbidity, higher cancer stage, greater than 50 miles travel distance, older age, living in the South, income < $50,353, and less education were associated with five-year cervical cancer survival. Citation Format: Sejong Bae, Vishruti Pandya, Hao Wang, Chenguang Wang, Warner K. Huh. Distance traveled for cervical cancer treatment and its impact on five-year survival [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr C084.